DCF — COXHEALTH
Enterprise Value: $-1.7B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.7B
Enterprise Value
$-557.8M
PV of Cash Flows
$-1.2B
PV of Terminal Value
$-1.9B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.4B | $-101.4M | -7.0% | $-161.5M | $-146.8M |
| Year 2 | $1.5B | $-89.8M | -6.0% | $-151.7M | $-125.4M |
| Year 3 | $1.5B | $-77.5M | -5.0% | $-141.2M | $-106.1M |
| Year 4 | $1.6B | $-72.0M | -5.0% | $-137.7M | $-94.0M |
| Year 5 | $1.6B | $-70.2M | -4.0% | $-137.8M | $-85.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.7B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0764413529862315
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5